Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C Amaya
Potential Mortality Reduction With Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Costa Rica
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Potential Mortality Reduction With Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Brazil
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcv105 - Potential Reduction in Mortality and Hospitalisations With Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure With Reduced Ejection Fraction in Ireland
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Reply: Sacubitril/Valsartan for Chagas' Heart Disease Heart Failure?
ESC heart failure
Cardiovascular Medicine
Cardiology
Cost-Effectiveness of Sacubitril/Valsartan in the Treatment of Heart Failure in Colombia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Reverse Remodeling Response to Sacubitril/Valsartan Therapy in Heart Failure With Reduced Ejection Fraction
Cardiovascular Therapeutics
Medicine
Cardiovascular Medicine
Pharmacology
Cardiology
Sacubitril-Valsartan in Heart Failure and Multimorbidity Patients
ESC heart failure
Cardiovascular Medicine
Cardiology
Profile of Sacubitril/Valsartan in the Treatment of Heart Failure: Patient Selection and Perspectives
Vascular Health and Risk Management
Perceived Barriers to Sacubitril/Valsartan Use in Patients With Heart Failure
Journal of Cardiac Failure
Cardiovascular Medicine
Cardiology
Pcv82 - Cost-Effectiveness of Sacubitril/Valsartan in the Treatment of Heart Failure With Reduced Ejection Fraction in Singapore
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
